Oramed Pharmaceutical’s phase 3 results for the oral insulin pill is just days away. Any thoughts on how it will play out?


The stock has been on a run since December 19th. Up $5.14 (+64.57%). My best guess is that it will keep clawing upwards the closer they get to the results (which are expected between the 15th and the end of the month.)

I bought around 19k @ $3.50 per share


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *